During the past decade, Polyclinique du Parc Rambot conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique du Parc Rambot" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Hospices Civils de Lyon" with 2 trials sponsored, "Centre Hospitalier Universitaire de Nīmes" with 1 trials sponsored, "Centre Oscar Lambret" with 1 trials sponsored and "European Georges Pompidou Hospital" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique du Parc Rambot" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "CTD-CNO" with 1 trials as a collaborator, "Evolucare Technologies" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator and "Laboratoire PRISM" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique du Parc Rambot" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Prostate Cancer" (2 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "Polyclinique du Parc Rambot" in a lesser frequency.

Most popular intervention types in "Polyclinique du Parc Rambot" are "Other" (7 trials), "Device" (4 trials), "Procedure" (4 trials), "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "MRI" (2 trials), "PSA dosage" (2 trials), "Prostatic biopsies" (2 trials) and "Questionnaires" (2 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique du Parc Rambot" are 10 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique du Parc Rambot". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Polyclinique du Parc Rambot, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique du Parc Rambot, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".